Literature DB >> 20791817

Nephrotoxic lesions from 5-aminosalicylic Acid.

I C Calder, C C Funder, C R Green, K N Ham, J D Tange.   

Abstract

5-Aminosalicylic acid given to rats as a single intravenous injection led to necrosis of the proximal convoluted tubules and of the renal papilla. These two lesions developed at the same time and the cortical lesions did not appear to be a consequence of the renal papillary necrosis. Since the compound possesses the molecular structure both of a phenacetin derivative and of a salicylate these observations may be relevant to the problem of renal damage incident to abuse of analgesic compounds and suggest the possibility that in this syndrome cortical lesions may develop independently of renal papillary necrosis.

Entities:  

Year:  1972        PMID: 20791817      PMCID: PMC1787127          DOI: 10.1136/bmj.1.5793.152

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  5 in total

1.  Distribution and metabolism of salicyl-azo-sulfapyridine. I. A study with C-14-5-amino-salicylic acid.

Authors:  A HANNGREN; E HANSSON; N SVARTZ; S ULLBERG
Journal:  Acta Med Scand       Date:  1963-01

2.  Potassium deficiency and the kidney.

Authors:  M D MILNE; R C MUEHRCKE; B E HEARD
Journal:  Br Med Bull       Date:  1957-01       Impact factor: 4.291

3.  Pathogenesis of the renal lesion associated with the abuse of analgesics.

Authors:  P Kincaid-Smith
Journal:  Lancet       Date:  1967-04-22       Impact factor: 79.321

4.  Kidney lesions induced in rats by p-aminophenol.

Authors:  C R Green; K N Ham; J D Tange
Journal:  Br Med J       Date:  1969-01-18

5.  Comparative nephrotoxicity of aspirin and phenacetin derivatives.

Authors:  I C Calder; C C Funder; C R Green; K N Ham; J D Tange
Journal:  Br Med J       Date:  1971-11-27
  5 in total
  23 in total

Review 1.  Drug therapy of ulcerative colitis.

Authors:  B Crotty; D P Jewell
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

Review 2.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 3.  Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy.

Authors:  A B Hawthorne; C J Hawkey
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

4.  New salicylates as maintenance treatment in ulcerative colitis.

Authors:  G Järnerot
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

Review 5.  Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics.

Authors:  L F Prescott
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

6.  Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion.

Authors:  M Campieri; G A Lanfranchi; S Boschi; C Brignola; G Bazzocchi; P Gionchetti; M R Minguzzi; A Belluzzi; G Labò
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

7.  Bioavailability of 5-aminosalicyclic acid from slow release 5-aminosalicyclic acid drug and sulfasalazine in normal children.

Authors:  L A Christensen; J Fallingborg; B A Jacobsen; K Abildgaard; H H Rasmussen; S N Rasmussen; S H Hansen
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

8.  Aspirin and analgesic nephropathy.

Authors:  A F Macklon; A W Craft; M Thompson; D N Kerr
Journal:  Br Med J       Date:  1974-03-30

9.  Interstitial nephritis from mesalazine: case report and literature review.

Authors:  Lois J Arend; James E Springate
Journal:  Pediatr Nephrol       Date:  2004-03-09       Impact factor: 3.714

10.  Renal function was not impaired by treatment with 5-aminosalicylic acid in rats and man.

Authors:  U Diener; H V Tuczek; C Fischer; K Maier; U Klotz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.